O'Donoghue Patrick, O'Halloran Aisling M, Kenny Rose Anne, Romero-Ortuno Roman
The Irish Longitudinal Study on Ageing, Trinity College Dublin, Dublin, Ireland.
School of Medicine, Trinity College Dublin, Dublin, Ireland.
EClinicalMedicine. 2022 Feb 19;45:101304. doi: 10.1016/j.eclinm.2022.101304. eCollection 2022 Mar.
The 2018 European Society of Cardiology/European Society of Hypertension (ESC/ESH) guidelines for management of hypertension in adults aged ≥65 years recommend a blood pressure (BP) treatment target of 130-139/70-79 mmHg if tolerated. Randomised controlled trials have advocated for lower BP, but this may have adverse outcomes in the frail. Yet, definitions of frailty vary.
Using a prospective, observational study design, we compared two frailty classifications in their ability to predict short-term adverse outcomes associated with intensive BP control (<130/70 mmHg) in The Irish Longitudinal Study on Ageing (TILDA). Data from participants aged ≥65 treated for hypertension in Wave 1 (W1) between October 2009 and June 2011 were analysed. Frailty was identified by Frailty Phenotype (FP) and the Clinical Frailty Scale (CFS). We formulated 8 participant groups based on frailty-BP combinations. Outcomes at wave 2 (W2) in 2012-2013 were analysed with adjusted binary logistic regression models.
Of 1920 W1 participants aged ≥65 and treated for hypertension, 1229 had full BP/FP and 1282 BP/CFS data. While the FP only identified risk of hospitalisation associated with intensive BP treatment, intensively treated frail-by-CFS participants had no increased or decreased risk of adverse outcomes, but those treated above the target had a higher risk of falls/fractures. In the non-frail by FP, intensive blood pressure treatment was associated with reduced risk of falls/fractures.
Different frailty classifications may have different prognostic implications for the purpose of the application of hypertension management guidelines. Our study had limited power due to low frailty prevalences, so further research is needed. Guidelines should specify the recommended frailty identification method/s. In the frail, therapy personalisation is needed.
2018年欧洲心脏病学会/欧洲高血压学会(ESC/ESH)关于≥65岁成年人高血压管理的指南建议,如果耐受,血压(BP)治疗目标为130 - 139/70 - 79 mmHg。随机对照试验主张更低的血压,但这可能对体弱的人产生不良后果。然而,体弱的定义各不相同。
采用前瞻性观察性研究设计,我们在爱尔兰老龄化纵向研究(TILDA)中比较了两种体弱分类方法预测与强化血压控制(<130/70 mmHg)相关的短期不良后果的能力。分析了2009年10月至2011年6月第1波(W1)中≥65岁接受高血压治疗的参与者的数据。通过体弱表型(FP)和临床体弱量表(CFS)确定体弱情况。我们根据体弱 - 血压组合制定了8个参与者组。使用调整后的二元逻辑回归模型分析2012 - 2013年第2波(W2)的结果。
在1920名≥65岁且接受高血压治疗的W1参与者中,1229人有完整的血压/FP数据,1282人有血压/CFS数据。虽然FP仅识别出与强化血压治疗相关的住院风险,但按CFS分类为体弱且接受强化治疗的参与者不良后果风险没有增加或降低,但治疗血压高于目标值的参与者跌倒/骨折风险更高。在按FP分类为非体弱的人群中,强化血压治疗与跌倒/骨折风险降低相关。
不同的体弱分类对于高血压管理指南的应用可能具有不同的预后意义。由于体弱患病率低,我们的研究效能有限,因此需要进一步研究。指南应指定推荐的体弱识别方法。对于体弱的人,需要进行个体化治疗方案。